{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:31:26Z","timestamp":1759617086427,"version":"3.40.3"},"publisher-location":"Cham","reference-count":221,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319571911"},{"type":"electronic","value":"9783319571935"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-57193-5_6","type":"book-chapter","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T09:03:24Z","timestamp":1499072604000},"page":"163-190","source":"Crossref","is-referenced-by-count":4,"title":["Motoneuron Disease: Basic Science"],"prefix":"10.1007","author":[{"given":"Hristelina","family":"Ilieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Maragakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"issue":"11","key":"6_CR1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","volume":"2","author":"DW Cleveland","year":"2001","unstructured":"Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2(11):806\u2013819","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"6_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/11640070-000000000-00000","volume":"26","author":"RE Seltman","year":"2012","unstructured":"Seltman RE, Matthews BR (2012) Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 26(10):841\u2013870","journal-title":"CNS Drugs"},{"issue":"1","key":"6_CR3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/17482968.2011.639376","volume":"13","author":"P Lillo","year":"2012","unstructured":"Lillo P et al (2012) Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler 13(1):102\u2013109","journal-title":"Amyotroph Lateral Scler"},{"issue":"7","key":"6_CR4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","volume":"59","author":"C Lomen-Hoerth","year":"2002","unstructured":"Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59(7):1077\u20131079","journal-title":"Neurology"},{"issue":"4","key":"6_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","volume":"81","author":"G Logroscino","year":"2010","unstructured":"Logroscino G et al (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81(4):385\u2013390","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.47.2.571","volume":"47","author":"V McGuire","year":"1996","unstructured":"McGuire V et al (1996) Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 47(2):571\u2013573","journal-title":"Neurology"},{"key":"6_CR7","doi-asserted-by":"crossref","unstructured":"Harper CJ, Sorenson EJ, Mandrekar J (2015) Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study. Amyotroph Lateral Scler Frontotemporal Degener (1\u20134)","DOI":"10.3109\/21678421.2015.1051991"},{"issue":"2","key":"6_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1212\/01.wnl.0000250339.14392.bb","volume":"68","author":"E Beghi","year":"2007","unstructured":"Beghi E et al (2007) Incidence of ALS in Lombardy, Italy. Neurology 68(2):141\u2013145","journal-title":"Neurology"},{"issue":"2","key":"6_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000120023","volume":"30","author":"MC Vazquez","year":"2008","unstructured":"Vazquez MC et al (2008) Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 30(2):105\u2013111","journal-title":"Neuroepidemiology"},{"issue":"8","key":"6_CR10","first-page":"727","volume":"44","author":"H Okumura","year":"1992","unstructured":"Okumura H et al (1992) Epidemiological study of motor neuron disease in Hokkaido island--its incidence, prevalence and regional distributions--ALS Study Group. No To Shinkei 44(8):727\u2013732","journal-title":"No To Shinkei"},{"issue":"12","key":"6_CR11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s00415-006-0195-y","volume":"253","author":"CA Johnston","year":"2006","unstructured":"Johnston CA et al (2006) Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 253(12):1642\u20131643","journal-title":"J Neurol"},{"key":"6_CR12","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre C et al (2015) Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol 7:181\u2013193","journal-title":"Clin Epidemiol"},{"issue":"3\u20134","key":"6_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/21678421.2014.992026","volume":"16","author":"A Lannuzel","year":"2015","unstructured":"Lannuzel A et al (2015) Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: a new focus of ALS associated with parkinsonism. Amyotroph Lateral Scler Frontotemporal Degener 16(3\u20134):216\u2013223","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"6_CR14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.59.5.773","volume":"59","author":"N Scarmeas","year":"2002","unstructured":"Scarmeas N et al (2002) Premorbid weight, body mass, and varsity athletics in ALS. Neurology 59(5):773\u2013775","journal-title":"Neurology"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/epirev\/mxu001","volume":"37","author":"JD Beard","year":"2015","unstructured":"Beard JD, Kamel F (2015) Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev 37:55\u201370","journal-title":"Epidemiol Rev"},{"issue":"7","key":"6_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10654-014-9923-2","volume":"29","author":"B Hamidou","year":"2014","unstructured":"Hamidou B et al (2014) Epidemiological evidence that physical activity is not a risk factor for ALS. Eur J Epidemiol 29(7):459\u2013475","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"6_CR17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jnnp-2012-304724","volume":"84","author":"MH Huisman","year":"2013","unstructured":"Huisman MH et al (2013) Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84(9):976\u2013981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"6_CR18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ana.24150","volume":"75","author":"E Pupillo","year":"2014","unstructured":"Pupillo E et al (2014) Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol 75(5):708\u2013716","journal-title":"Ann Neurol"},{"issue":"12","key":"6_CR19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1468-1331.2012.03723.x","volume":"19","author":"E Pupillo","year":"2012","unstructured":"Pupillo E et al (2012) Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol 19(12):1509\u20131517","journal-title":"Eur J Neurol"},{"issue":"4","key":"6_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/21678421.2012.754043","volume":"14","author":"TL Peters","year":"2013","unstructured":"Peters TL et al (2013) Severe head injury and amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14(4):267\u2013272","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"6_CR21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.20316","volume":"57","author":"A Ascherio","year":"2005","unstructured":"Ascherio A et al (2005) Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol 57(1):104\u2013110","journal-title":"Ann Neurol"},{"issue":"6","key":"6_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/aje\/kwq416","volume":"173","author":"H Wang","year":"2011","unstructured":"Wang H et al (2011) Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol 173(6):595\u2013602","journal-title":"Am J Epidemiol"},{"issue":"9","key":"6_CR23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamaneurol.2014.1214","volume":"71","author":"KC Fitzgerald","year":"2014","unstructured":"Fitzgerald KC et al (2014) Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol 71(9):1102\u20131110","journal-title":"JAMA Neurol"},{"issue":"4","key":"6_CR24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","volume":"78","author":"JH Veldink","year":"2007","unstructured":"Veldink JH et al (2007) Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78(4):367\u2013371","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"6_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00702-004-0220-1","volume":"112","author":"M Graf","year":"2005","unstructured":"Graf M et al (2005) High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 112(5):649\u2013660","journal-title":"J Neural Transm"},{"issue":"1","key":"6_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","volume":"2","author":"C Desnuelle","year":"2001","unstructured":"Desnuelle C et al (2001) A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol study group. Amyotroph Lateral Scler Other Motor Neuron Disord 2(1):9\u201318","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"10","key":"6_CR27","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/aje\/kwq063","volume":"171","author":"F Fang","year":"2010","unstructured":"Fang F et al (2010) Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol 171(10):1126\u20131133","journal-title":"Am J Epidemiol"},{"issue":"7","key":"6_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1258\/ebm.2012.011396","volume":"237","author":"PM Roos","year":"2012","unstructured":"Roos PM et al (2012) Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) 237(7):803\u2013810","journal-title":"Exp Biol Med (Maywood)"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2013.02.003","volume":"36","author":"M Meyer-Baron","year":"2013","unstructured":"Meyer-Baron M et al (2013) The neurobehavioral impact of manganese: results and challenges obtained by a meta-analysis of individual participant data. Neurotoxicology 36:1\u20139","journal-title":"Neurotoxicology"},{"issue":"3","key":"6_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuro.2012.04.001","volume":"33","author":"F Kamel","year":"2012","unstructured":"Kamel F et al (2012) Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology 33(3):457\u2013462","journal-title":"Neurotoxicology"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.envres.2012.06.007","volume":"117","author":"AM Malek","year":"2012","unstructured":"Malek AM et al (2012) Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res 117:112\u2013119","journal-title":"Environ Res"},{"issue":"6","key":"6_CR32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.58.6.956","volume":"58","author":"PA Cox","year":"2002","unstructured":"Cox PA, Sacks OW (2002) Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58(6):956\u2013959","journal-title":"Neurology"},{"issue":"5\u20136","key":"6_CR33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/21678421.2012.750364","volume":"14","author":"WG Bradley","year":"2013","unstructured":"Bradley WG et al (2013) Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases? Amyotroph Lateral Scler Frontotemporal Degener 14(5\u20136):325\u2013333","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"6_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","volume":"11","author":"X Paez-Colasante","year":"2015","unstructured":"Paez-Colasante X et al (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 11(5):266\u2013279","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"6_CR35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp.2010.207464","volume":"81","author":"A Al-Chalabi","year":"2010","unstructured":"Al-Chalabi A et al (2010) An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81(12):1324\u20131326","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"6_CR36","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1172\/JCI82693","volume":"125","author":"OM Peters","year":"2015","unstructured":"Peters OM, Ghasemi M, Brown RH Jr (2015) Emerging mechanisms of molecular pathology in ALS. J Clin Invest 125(6):2548","journal-title":"J Clin Invest"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2014.10.009","volume":"1607","author":"G Marangi","year":"2015","unstructured":"Marangi G, Traynor BJ (2015) Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res 1607:75\u201393","journal-title":"Brain Res"},{"issue":"5796","key":"6_CR38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133","journal-title":"Science"},{"issue":"5918","key":"6_CR39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski TJ Jr et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205\u20131208","journal-title":"Science"},{"issue":"5918","key":"6_CR40","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208\u20131211","journal-title":"Science"},{"issue":"6","key":"6_CR41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","volume":"136","author":"C Lagier-Tourenne","year":"2009","unstructured":"Lagier-Tourenne C, Cleveland DW (2009) Rethinking ALS: the FUS about TDP-43. Cell 136(6):1001\u20131004","journal-title":"Cell"},{"issue":"7442","key":"6_CR42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","volume":"495","author":"HJ Kim","year":"2013","unstructured":"Kim HJ et al (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495(7442):467\u2013473","journal-title":"Nature"},{"issue":"2","key":"6_CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng.2007.65","volume":"40","author":"HO Nousiainen","year":"2008","unstructured":"Nousiainen HO et al (2008) Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nat Genet 40(2):155\u2013157","journal-title":"Nat Genet"},{"issue":"5","key":"6_CR44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","volume":"17","author":"JO Johnson","year":"2014","unstructured":"Johnson JO et al (2014) Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 17(5):664\u2013666","journal-title":"Nat Neurosci"},{"issue":"2","key":"6_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245\u2013256","journal-title":"Neuron"},{"issue":"2","key":"6_CR46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257\u2013268","journal-title":"Neuron"},{"issue":"1","key":"6_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(11)70261-7","volume":"11","author":"I Gijselinck","year":"2012","unstructured":"Gijselinck I et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11(1):54\u201365","journal-title":"Lancet Neurol"},{"issue":"4","key":"6_CR48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/bioinformatics\/bts725","volume":"29","author":"TP Levine","year":"2013","unstructured":"Levine TP et al (2013) The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 29(4):499\u2013503","journal-title":"Bioinformatics"},{"issue":"13","key":"6_CR49","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/hmg\/ddu068","volume":"23","author":"MA Farg","year":"2014","unstructured":"Farg MA et al (2014) C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet 23(13):3579\u20133595","journal-title":"Hum Mol Genet"},{"issue":"3","key":"6_CR50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.21948","volume":"67","author":"PK Todd","year":"2010","unstructured":"Todd PK, Paulson HL (2010) RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol 67(3):291\u2013300","journal-title":"Ann Neurol"},{"issue":"3","key":"6_CR51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79(3):416\u2013438","journal-title":"Neuron"},{"issue":"6","key":"6_CR52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0b013e32835a3efb","volume":"25","author":"M Blitterswijk van","year":"2012","unstructured":"van Blitterswijk M, DeJesus-Hernandez M, Rademakers R (2012) How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol 25(6):689\u2013700","journal-title":"Curr Opin Neurol"},{"issue":"21","key":"6_CR53","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1093\/hmg\/ddu279","volume":"23","author":"Z Xi","year":"2014","unstructured":"Xi Z et al (2014) Hypermethylation of the CpG-island near the C9orf72 G(4)C(2)-repeat expansion in FTLD patients. Hum Mol Genet 23(21):5630\u20135637","journal-title":"Hum Mol Genet"},{"issue":"5","key":"6_CR54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-015-1401-8","volume":"129","author":"Z Xi","year":"2015","unstructured":"Xi Z et al (2015) The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol 129(5):715\u2013727","journal-title":"Acta Neuropathol"},{"issue":"6","key":"6_CR55","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajhg.2013.04.017","volume":"92","author":"Z Xi","year":"2013","unstructured":"Xi Z et al (2013) Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 92(6):981\u2013989","journal-title":"Am J Hum Genet"},{"issue":"6125","key":"6_CR56","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori K et al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS. Science 339(6125):1335\u20131338","journal-title":"Science"},{"issue":"4","key":"6_CR57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash PE et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77(4):639\u2013646","journal-title":"Neuron"},{"issue":"4","key":"6_CR58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie E et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11(4):323\u2013330","journal-title":"Lancet Neurol"},{"issue":"1","key":"6_CR59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ejhg.2012.98","volume":"21","author":"BN Smith","year":"2013","unstructured":"Smith BN et al (2013) The C9ORF72 expansion mutation is a common cause of ALS+\/\u2212 FTD in Europe and has a single founder. Eur J Hum Genet 21(1):102\u2013108","journal-title":"Eur J Hum Genet"},{"issue":"7363","key":"6_CR60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"HX Deng","year":"2011","unstructured":"Deng HX et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477(7363):211\u2013215","journal-title":"Nature"},{"issue":"2","key":"6_CR61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuron.2014.09.027","volume":"84","author":"BN Smith","year":"2014","unstructured":"Smith BN et al (2014) Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84(2):324\u2013331","journal-title":"Neuron"},{"issue":"44","key":"6_CR62","doi-asserted-by":"crossref","first-page":"45951","DOI":"10.1074\/jbc.M408139200","volume":"279","author":"F Gros-Louis","year":"2004","unstructured":"Gros-Louis F et al (2004) A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 279(44):45951\u201345956","journal-title":"J Biol Chem"},{"issue":"7412","key":"6_CR63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature11280","volume":"488","author":"CH Wu","year":"2012","unstructured":"Wu CH et al (2012) Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488(7412):499\u2013503","journal-title":"Nature"},{"issue":"8","key":"6_CR64","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0000000000001862","volume":"85","author":"JP Taylor","year":"2015","unstructured":"Taylor JP (2015) Multisystem proteinopathy: intersecting genetics in muscle, bone, and brain degeneration. Neurology 85(8):658\u2013660","journal-title":"Neurology"},{"issue":"22","key":"6_CR65","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1073\/pnas.0812937106","volume":"106","author":"JE Landers","year":"2009","unstructured":"Landers JE et al (2009) Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 106(22):9004\u20139009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6_CR66","doi-asserted-by":"crossref","first-page":"2420e13\u20134","DOI":"10.1016\/j.neurobiolaging.2014.04.014","volume":"35","author":"PT Doormaal van","year":"2014","unstructured":"van Doormaal PT et al (2014) Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study. Neurobiol Aging 35(10):2420e13\u20134","journal-title":"Neurobiol Aging"},{"issue":"6","key":"6_CR67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.22611","volume":"70","author":"MA Es van","year":"2011","unstructured":"van Es MA et al (2011) Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 70(6):964\u2013973","journal-title":"Ann Neurol"},{"issue":"7310","key":"6_CR68","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069\u20131075","journal-title":"Nature"},{"issue":"3","key":"6_CR69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.0000000000001159","volume":"84","author":"A Chio","year":"2015","unstructured":"Chio A et al (2015) ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology 84(3):251\u2013258","journal-title":"Neurology"},{"issue":"10","key":"6_CR70","doi-asserted-by":"crossref","first-page":"2421e13\u20137","DOI":"10.1016\/j.neurobiolaging.2014.04.016","volume":"35","author":"M Blitterswijk van","year":"2014","unstructured":"van Blitterswijk M et al (2014) Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging 35(10):2421e13\u20137","journal-title":"Neurobiol Aging"},{"issue":"17","key":"6_CR71","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/hmg\/dds199","volume":"21","author":"M Blitterswijk van","year":"2012","unstructured":"van Blitterswijk M et al (2012) Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 21(17):3776\u20133784","journal-title":"Hum Mol Genet"},{"issue":"4","key":"6_CR72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14(4):459\u2013468","journal-title":"Nat Neurosci"},{"issue":"4","key":"6_CR73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey JR et al (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14(4):452\u2013458","journal-title":"Nat Neurosci"},{"issue":"7014","key":"6_CR74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","volume":"432","author":"RI Gregory","year":"2004","unstructured":"Gregory RI et al (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432(7014):235\u2013240","journal-title":"Nature"},{"issue":"30","key":"6_CR75","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.1008227107","volume":"107","author":"SC Ling","year":"2010","unstructured":"Ling SC et al (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS\/TLS. Proc Natl Acad Sci U S A 107(30):13318\u201313323","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6_CR76","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/pr901076y","volume":"9","author":"BD Freibaum","year":"2010","unstructured":"Freibaum BD et al (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9(2):1104\u20131120","journal-title":"J Proteome Res"},{"issue":"11","key":"6_CR77","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nn.3230","volume":"15","author":"C Lagier-Tourenne","year":"2012","unstructured":"Lagier-Tourenne C et al (2012) Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15(11):1488\u20131497","journal-title":"Nat Neurosci"},{"key":"6_CR78","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/srep00603","volume":"2","author":"B Rogelj","year":"2012","unstructured":"Rogelj B et al (2012) Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2:603","journal-title":"Sci Rep"},{"issue":"3","key":"6_CR79","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","volume":"81","author":"NH Alami","year":"2014","unstructured":"Alami NH et al (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81(3):536\u2013543","journal-title":"Neuron"},{"issue":"9","key":"6_CR80","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1074\/jbc.M109.061846","volume":"285","author":"CF Sephton","year":"2010","unstructured":"Sephton CF et al (2010) TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 285(9):6826\u20136834","journal-title":"J Biol Chem"},{"issue":"4","key":"6_CR81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-010-0659-0","volume":"119","author":"BC Kraemer","year":"2010","unstructured":"Kraemer BC et al (2010) Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 119(4):409\u2013419","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6_CR82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/dvg.20584","volume":"48","author":"LS Wu","year":"2010","unstructured":"Wu LS et al (2010) TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 48(1):56\u201362","journal-title":"Genesis"},{"issue":"13","key":"6_CR83","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1073\/pnas.1218311110","volume":"110","author":"B Schmid","year":"2013","unstructured":"Schmid B et al (2013) Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A 110(13):4986\u20134991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6_CR84","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.febslet.2009.04.019","volume":"583","author":"F Feiguin","year":"2009","unstructured":"Feiguin F et al (2009) Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett 583(10):1586\u20131592","journal-title":"FEBS Lett"},{"issue":"37","key":"6_CR85","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1073\/pnas.1002176107","volume":"107","author":"PM Chiang","year":"2010","unstructured":"Chiang PM et al (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A 107(37):16320\u201316324","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 5","key":"6_CR86","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/brain\/awt029","volume":"136","author":"Y Iguchi","year":"2013","unstructured":"Iguchi Y et al (2013) Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136(Pt 5):1371\u20131382","journal-title":"Brain"},{"issue":"33","key":"6_CR87","doi-asserted-by":"crossref","first-page":"27335","DOI":"10.1074\/jbc.M112.359000","volume":"287","author":"LS Wu","year":"2012","unstructured":"Wu LS, Cheng WC, Shen CK (2012) Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem 287(33):27335\u201327344","journal-title":"J Biol Chem"},{"key":"6_CR88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2012.02.032","volume":"1462","author":"CM Dewey","year":"2012","unstructured":"Dewey CM et al (2012) TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res 1462:16\u201325","journal-title":"Brain Res"},{"issue":"3","key":"6_CR89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.201302044","volume":"201","author":"YR Li","year":"2013","unstructured":"Li YR et al (2013) Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201(3):361\u2013372","journal-title":"J Cell Biol"},{"issue":"5","key":"6_CR90","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/MCB.01279-10","volume":"31","author":"CM Dewey","year":"2011","unstructured":"Dewey CM et al (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 31(5):1098\u20131108","journal-title":"Mol Cell Biol"},{"key":"6_CR91","doi-asserted-by":"crossref","unstructured":"Liu-Yesucevitz, L., et al., Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One, 2010. 5(10): p. e13250.","DOI":"10.1371\/journal.pone.0013250"},{"key":"6_CR92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2121-9-37","volume":"9","author":"MK Andersson","year":"2008","unstructured":"Andersson MK et al (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 9:37","journal-title":"BMC Cell Biol"},{"issue":"21","key":"6_CR93","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/hmg\/ddq335","volume":"19","author":"DA Bosco","year":"2010","unstructured":"Bosco DA et al (2010) Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19(21):4160\u20134175","journal-title":"Hum Mol Genet"},{"issue":"16","key":"6_CR94","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","volume":"29","author":"D Dormann","year":"2010","unstructured":"Dormann D et al (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29(16):2841\u20132857","journal-title":"EMBO J"},{"issue":"12","key":"6_CR95","first-page":"2323e27\u201340","volume":"32","author":"J Gal","year":"2011","unstructured":"Gal J et\u00a0al (2011) Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 32(12):2323e27\u201340","journal-title":"Neurobiol Aging"},{"issue":"7","key":"6_CR96","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/nar\/gkq1162","volume":"39","author":"Y Kino","year":"2011","unstructured":"Kino Y et al (2011) Intracellular localization and splicing regulation of FUS\/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res 39(7):2781\u20132798","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6_CR97","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1083\/jcb.201306058","volume":"203","author":"K Yasuda","year":"2013","unstructured":"Yasuda K et al (2013) The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J Cell Biol 203(5):737\u2013746","journal-title":"J Cell Biol"},{"issue":"2","key":"6_CR98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-1789.2007.00873.x","volume":"28","author":"K Okamoto","year":"2008","unstructured":"Okamoto K, Mizuno Y, Fujita Y (2008) Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 28(2):109\u2013115","journal-title":"Neuropathology"},{"key":"6_CR99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298","journal-title":"Annu Rev Neurosci"},{"issue":"28","key":"6_CR100","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1073\/pnas.0501957102","volume":"102","author":"MJ Lindberg","year":"2005","unstructured":"Lindberg MJ et al (2005) Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc Natl Acad Sci U S A 102(28):9754\u20139759","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"6_CR101","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2003.11.008","volume":"312","author":"J Chung","year":"2003","unstructured":"Chung J et\u00a0al (2003) Cu\/Zn superoxide dismutase can form pore-like structures. Biochem Biophys Res Commun 312(4):873\u2013876","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"6_CR102","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.1074\/jbc.M113.542613","volume":"289","author":"J Kim","year":"2014","unstructured":"Kim J et\u00a0al (2014) Dimerization, oligomerization, and aggregation of human amyotrophic lateral sclerosis copper\/zinc superoxide dismutase 1 protein mutant forms in live cells. J Biol Chem 289(21):15094\u201315103","journal-title":"J Biol Chem"},{"issue":"11","key":"6_CR103","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco DA et al (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13(11):1396\u20131403","journal-title":"Nat Neurosci"},{"key":"6_CR104","doi-asserted-by":"crossref","unstructured":"Forsberg, K., et al., Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One, 2010. 5(7): p. e11552.","DOI":"10.1371\/journal.pone.0011552"},{"issue":"3","key":"6_CR105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00401-010-0646-5","volume":"119","author":"A Kerman","year":"2010","unstructured":"Kerman A et al (2010) Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol 119(3):335\u2013344","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6_CR106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.21704","volume":"66","author":"HN Liu","year":"2009","unstructured":"Liu HN et al (2009) Lack of evidence of monomer\/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol 66(1):75\u201380","journal-title":"Ann Neurol"},{"issue":"1","key":"6_CR107","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","volume":"86","author":"A Israelson","year":"2015","unstructured":"Israelson A et al (2015) Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron 86(1):218\u2013232","journal-title":"Neuron"},{"issue":"6438","key":"6_CR108","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/364584a0","volume":"364","author":"JS Beckman","year":"1993","unstructured":"Beckman JS et al (1993) ALS, SOD and peroxynitrite. Nature 364(6438):584","journal-title":"Nature"},{"issue":"5449","key":"6_CR109","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1126\/science.286.5449.2498","volume":"286","author":"AG Estevez","year":"1999","unstructured":"Estevez AG et al (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286(5449):2498\u20132500","journal-title":"Science"},{"issue":"2","key":"6_CR110","first-page":"659","volume":"118","author":"MM Harraz","year":"2008","unstructured":"Harraz MM et al (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118(2):659\u2013670","journal-title":"J Clin Invest"},{"issue":"33","key":"6_CR111","doi-asserted-by":"crossref","first-page":"29771","DOI":"10.1074\/jbc.M504039200","volume":"280","author":"A Tiwari","year":"2005","unstructured":"Tiwari A, Xu Z, Hayward LJ (2005) Aberrantly increased hydrophobicity shared by mutants of cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J Biol Chem 280(33):29771\u201329779","journal-title":"J Biol Chem"},{"issue":"1","key":"6_CR112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","volume":"38","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD et al (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38(1):73\u201384","journal-title":"Ann Neurol"},{"issue":"43","key":"6_CR113","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1523\/JNEUROSCI.1340-08.2008","volume":"28","author":"B Zundert van","year":"2008","unstructured":"van Zundert B et al (2008) Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28(43):10864\u201310874","journal-title":"J Neurosci"},{"issue":"5","key":"6_CR114","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn.2297","volume":"12","author":"S Saxena","year":"2009","unstructured":"Saxena S, Cabuy E, Caroni P (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12(5):627\u2013636","journal-title":"Nat Neurosci"},{"issue":"1","key":"6_CR115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1523\/JNEUROSCI.1233-11.2012","volume":"32","author":"J Magrane","year":"2012","unstructured":"Magrane J et\u00a0al (2012) Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci 32(1):229\u2013242","journal-title":"J Neurosci"},{"key":"6_CR116","doi-asserted-by":"crossref","unstructured":"Vande Velde, C., et al., Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One, 2011. 6(7): p. e22031.","DOI":"10.1371\/journal.pone.0022031"},{"issue":"4","key":"6_CR117","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2010.07.019","volume":"67","author":"A Israelson","year":"2010","unstructured":"Israelson A et al (2010) Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67(4):575\u2013587","journal-title":"Neuron"},{"issue":"1","key":"6_CR118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/4553","volume":"2","author":"TL Williamson","year":"1999","unstructured":"Williamson TL, Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2(1):50\u201356","journal-title":"Nat Neurosci"},{"key":"6_CR119","doi-asserted-by":"crossref","unstructured":"Morfini, G.A., et al., Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One, 2013. 8(6): p. e65235.","DOI":"10.1371\/journal.pone.0065235"},{"issue":"3","key":"6_CR120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nn1653","volume":"9","author":"S Pun","year":"2006","unstructured":"Pun S et al (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9(3):408\u2013419","journal-title":"Nat Neurosci"},{"issue":"3","key":"6_CR121","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"6_CR122","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67(6):555\u2013564","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"6_CR123","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C et al (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67(12):1159\u20131165","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 5","key":"6_CR124","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/brain\/awm065","volume":"130","author":"M Hasegawa","year":"2007","unstructured":"Hasegawa M et al (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130(Pt 5):1386\u20131394","journal-title":"Brain"},{"issue":"19","key":"6_CR125","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai Y et al (2008) Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 582(19):2899\u20132904","journal-title":"FEBS Lett"},{"issue":"1","key":"6_CR126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/ijms10010232","volume":"10","author":"M Neumann","year":"2009","unstructured":"Neumann M (2009) Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 10(1):232\u2013246","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6_CR127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1440-1789.2009.01089.x","volume":"30","author":"T Arai","year":"2010","unstructured":"Arai T et al (2010) Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30(2):170\u2013181","journal-title":"Neuropathology"},{"issue":"15\u201316","key":"6_CR128","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/pmic.201200006","volume":"12","author":"JH Herskowitz","year":"2012","unstructured":"Herskowitz JH et al (2012) Asparaginyl endopeptidase cleaves TDP-43 in brain. Proteomics 12(15\u201316):2455\u20132463","journal-title":"Proteomics"},{"issue":"5","key":"6_CR129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-006-0189-y","volume":"113","author":"Y Davidson","year":"2007","unstructured":"Davidson Y et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113(5):521\u2013533","journal-title":"Acta Neuropathol"},{"issue":"3","key":"6_CR130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4161\/pri.5.3.17230","volume":"5","author":"AD Gitler","year":"2011","unstructured":"Gitler AD, Shorter J (2011) RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5(3):179\u2013187","journal-title":"Prion"},{"issue":"13","key":"6_CR131","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/hmg\/ddt117","volume":"22","author":"C Vance","year":"2013","unstructured":"Vance C et al (2013) ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet 22(13):2676\u20132688","journal-title":"Hum Mol Genet"},{"issue":"5","key":"6_CR132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","volume":"162","author":"A Patel","year":"2015","unstructured":"Patel A et al (2015) A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162(5):1066\u20131077","journal-title":"Cell"},{"key":"6_CR133","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.1038\/srep13416","volume":"5","author":"NE Farrawell","year":"2015","unstructured":"Farrawell NE et al (2015) Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci Rep 5:13416","journal-title":"Sci Rep"},{"issue":"3","key":"6_CR134","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1750-3639.2009.00337.x","volume":"20","author":"J Woulfe","year":"2010","unstructured":"Woulfe J, Gray DA, Mackenzie IR (2010) FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 20(3):589\u2013597","journal-title":"Brain Pathol"},{"issue":"1","key":"6_CR135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","volume":"163","author":"A Molliex","year":"2015","unstructured":"Molliex A et al (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163(1):123\u2013133","journal-title":"Cell"},{"issue":"6","key":"6_CR136","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","volume":"126","author":"TF Gendron","year":"2013","unstructured":"Gendron TF et al (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS. Acta Neuropathol 126(6):829\u2013844","journal-title":"Acta Neuropathol"},{"issue":"5","key":"6_CR137","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","volume":"83","author":"Z Su","year":"2014","unstructured":"Su Z et al (2014) Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS. Neuron 83(5):1043\u20131050","journal-title":"Neuron"},{"issue":"6201","key":"6_CR138","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1256800","volume":"345","author":"S Mizielinska","year":"2014","unstructured":"Mizielinska S et al (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345(6201):1192\u20131194","journal-title":"Science"},{"issue":"7567","key":"6_CR139","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","volume":"525","author":"BD Freibaum","year":"2015","unstructured":"Freibaum BD et al (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525(7567):129\u2013133","journal-title":"Nature"},{"issue":"9","key":"6_CR140","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","volume":"18","author":"A Jovicic","year":"2015","unstructured":"Jovicic A et al (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS. Nat Neurosci 18(9):1226\u20131229","journal-title":"Nat Neurosci"},{"issue":"6","key":"6_CR141","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.neuron.2014.12.010","volume":"84","author":"X Wen","year":"2014","unstructured":"Wen X et al (2014) Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS\/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84(6):1213\u20131225","journal-title":"Neuron"},{"issue":"6201","key":"6_CR142","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1254917","volume":"345","author":"I Kwon","year":"2014","unstructured":"Kwon I et al (2014) Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345(6201):1139\u20131145","journal-title":"Science"},{"issue":"8","key":"6_CR143","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19(8):983\u2013997","journal-title":"Nat Med"},{"issue":"40","key":"6_CR144","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.1405741111","volume":"111","author":"GH Gorrie","year":"2014","unstructured":"Gorrie GH et al (2014) Dendritic spinopathy in transgenic mice expressing ALS\/dementia-linked mutant UBQLN2. Proc Natl Acad Sci U S A 111(40):14524\u201314529","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-015-0026-7","volume":"10","author":"C Ceballos-Diaz","year":"2015","unstructured":"Ceballos-Diaz C et al (2015) Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Mol Neurodegener 10:25","journal-title":"Mol Neurodegener"},{"issue":"6","key":"6_CR146","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00401-012-0970-z","volume":"123","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J et\u00a0al (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 123(6):825\u2013839","journal-title":"Acta Neuropathol"},{"issue":"11","key":"6_CR147","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto F et al (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68(11):1440\u20131446","journal-title":"Arch Neurol"},{"issue":"6","key":"6_CR148","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/hmg\/ddu580","volume":"24","author":"S Lattante","year":"2015","unstructured":"Lattante S et al (2015) Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS\/FTLD. Hum Mol Genet 24(6):1682\u20131690","journal-title":"Hum Mol Genet"},{"issue":"8","key":"6_CR149","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000001864","volume":"85","author":"RC Bucelli","year":"2015","unstructured":"Bucelli RC et al (2015) SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 85(8):665\u2013674","journal-title":"Neurology"},{"issue":"22","key":"6_CR150","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","volume":"11","author":"LJ Hocking","year":"2002","unstructured":"Hocking LJ et al (2002) Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget\u2019s disease. Hum Mol Genet 11(22):2735\u20132739","journal-title":"Hum Mol Genet"},{"issue":"20","key":"6_CR151","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.0b013e3182929fc3","volume":"80","author":"M Benatar","year":"2013","unstructured":"Benatar M et al (2013) Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 80(20):1874\u20131880","journal-title":"Neurology"},{"issue":"2","key":"6_CR152","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/auto.6.2.11014","volume":"6","author":"E Tresse","year":"2010","unstructured":"Tresse E et al (2010) VCP\/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6(2):217\u2013227","journal-title":"Autophagy"},{"issue":"5","key":"6_CR153","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt A et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18(5):631\u2013636","journal-title":"Nat Neurosci"},{"issue":"2","key":"6_CR154","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.23946","volume":"74","author":"S Ciura","year":"2013","unstructured":"Ciura S et al (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 74(2):180\u2013187","journal-title":"Ann Neurol"},{"issue":"3","key":"6_CR155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","volume":"78","author":"M Koppers","year":"2015","unstructured":"Koppers M et al (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol 78(3):426\u2013438","journal-title":"Ann Neurol"},{"issue":"3","key":"6_CR156","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-013-1147-0","volume":"126","author":"P Fratta","year":"2013","unstructured":"Fratta P et al (2013) Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol 126(3):401\u2013409","journal-title":"Acta Neuropathol"},{"issue":"7491","key":"6_CR157","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","volume":"507","author":"AR Haeusler","year":"2014","unstructured":"Haeusler AR et al (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507(7491):195\u2013200","journal-title":"Nature"},{"issue":"24","key":"6_CR158","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang H et al (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13(24):3079\u20133088","journal-title":"Hum Mol Genet"},{"issue":"5652","key":"6_CR159","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia RN et al (2003) A muscleblind knockout model for myotonic dystrophy. Science 302(5652):1978\u20131980","journal-title":"Science"},{"issue":"19","key":"6_CR160","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.1219643110","volume":"110","author":"Z Xu","year":"2013","unstructured":"Xu Z et al (2013) Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci U S A 110(19):7778\u20137783","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6_CR161","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","volume":"80","author":"CJ Donnelly","year":"2013","unstructured":"Donnelly CJ et al (2013) RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80(2):415\u2013428","journal-title":"Neuron"},{"issue":"Pt 6","key":"6_CR162","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1042\/BST0371281","volume":"37","author":"JE Lee","year":"2009","unstructured":"Lee JE, Cooper TA (2009) Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 37(Pt 6):1281\u20131286","journal-title":"Biochem Soc Trans"},{"issue":"7567","key":"6_CR163","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang K et al (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525(7567):56\u201361","journal-title":"Nature"},{"issue":"47","key":"6_CR164","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","volume":"110","author":"C Lagier-Tourenne","year":"2013","unstructured":"Lagier-Tourenne C et al (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A 110(47):E4530\u2013E4539","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6_CR165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-015-0218-y","volume":"3","author":"J Gomez-Deza","year":"2015","unstructured":"Gomez-Deza J et\u00a0al (2015) Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol Commun 3(1):38","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"6_CR166","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-015-1474-4","volume":"130","author":"TF Gendron","year":"2015","unstructured":"Gendron TF et al (2015) Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol 130(4):559\u2013573","journal-title":"Acta Neuropathol"},{"key":"6_CR167","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1989.tb12512.x","volume":"568","author":"RC Henneberry","year":"1989","unstructured":"Henneberry RC et al (1989) Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease. Ann N Y Acad Sci 568:225\u2013233","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"6_CR168","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","volume":"326","author":"JD Rothstein","year":"1992","unstructured":"Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326(22):1464\u20131468","journal-title":"N Engl J Med"},{"issue":"2","key":"6_CR169","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","volume":"18","author":"LI Bruijn","year":"1997","unstructured":"Bruijn LI et al (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18(2):327\u2013338","journal-title":"Neuron"},{"issue":"3","key":"6_CR170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/glia.20922","volume":"58","author":"Y Yang","year":"2010","unstructured":"Yang Y et al (2010) Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia 58(3):277\u2013286","journal-title":"Glia"},{"issue":"6","key":"6_CR171","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.neuron.2009.02.010","volume":"61","author":"Y Yang","year":"2009","unstructured":"Yang Y et al (2009) Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron 61(6):880\u2013894","journal-title":"Neuron"},{"issue":"6977","key":"6_CR172","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/427801a","volume":"427","author":"Y Kawahara","year":"2004","unstructured":"Kawahara Y et al (2004) Glutamate receptors: RNA editing and death of motor neurons. Nature 427(6977):801","journal-title":"Nature"},{"issue":"3","key":"6_CR173","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02036-5","volume":"308","author":"T Murakami","year":"2001","unstructured":"Murakami T et al (2001) Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene. Neurosci Lett 308(3):149\u2013152","journal-title":"Neurosci Lett"},{"issue":"31","key":"6_CR174","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1523\/JNEUROSCI.0813-09.2009","volume":"29","author":"E Perlson","year":"2009","unstructured":"Perlson E et al (2009) A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J Neurosci 29(31):9903\u20139917","journal-title":"J Neurosci"},{"issue":"14","key":"6_CR175","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1073\/pnas.1303279110","volume":"110","author":"Y Song","year":"2013","unstructured":"Song Y et al (2013) Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proc Natl Acad Sci U S A 110(14):5428\u20135433","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6_CR176","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/hmg\/3.10.1757","volume":"3","author":"DA Figlewicz","year":"1994","unstructured":"Figlewicz DA et al (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3(10):1757\u20131761","journal-title":"Hum Mol Genet"},{"issue":"17","key":"6_CR177","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1097\/00001756-199812010-00036","volume":"9","author":"J Tomkins","year":"1998","unstructured":"Tomkins J et\u00a0al (1998) Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9(17):3967\u20133970","journal-title":"Neuroreport"},{"issue":"2","key":"6_CR178","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/hmg\/8.2.157","volume":"8","author":"A Al-Chalabi","year":"1999","unstructured":"Al-Chalabi A et al (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8(2):157\u2013164","journal-title":"Hum Mol Genet"},{"issue":"3","key":"6_CR179","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1750-3639.2004.tb00066.x","volume":"14","author":"CL Leung","year":"2004","unstructured":"Leung CL et al (2004) A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol 14(3):290\u2013296","journal-title":"Brain Pathol"},{"issue":"3","key":"6_CR180","doi-asserted-by":"crossref","first-page":"552e1\u20136","DOI":"10.1016\/j.neurobiolaging.2010.02.011","volume":"32","author":"L Corrado","year":"2011","unstructured":"Corrado L et al (2011) A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Neurobiol Aging 32(3):552e1\u20136","journal-title":"Neurobiol Aging"},{"issue":"4","key":"6_CR181","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng1123","volume":"33","author":"I Puls","year":"2003","unstructured":"Puls I et al (2003) Mutant dynactin in motor neuron disease. Nat Genet 33(4):455\u2013456","journal-title":"Nat Genet"},{"issue":"5642","key":"6_CR182","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement AM et al (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302(5642):113\u2013117","journal-title":"Science"},{"issue":"5","key":"6_CR183","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong X et al (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci 17(5):694\u2013703","journal-title":"Nat Neurosci"},{"issue":"6","key":"6_CR184","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I et al (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45(6):847\u2013859","journal-title":"Neuron"},{"issue":"10","key":"6_CR185","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nn1750","volume":"9","author":"SK Custer","year":"2006","unstructured":"Custer SK et al (2006) Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 9(10):1302\u20131311","journal-title":"Nat Neurosci"},{"issue":"5","key":"6_CR186","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai M et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615\u2013622","journal-title":"Nat Neurosci"},{"issue":"9","key":"6_CR187","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","volume":"29","author":"AM Haidet-Phillips","year":"2011","unstructured":"Haidet-Phillips AM et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29(9):824\u2013828","journal-title":"Nat Biotechnol"},{"issue":"5","key":"6_CR188","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","volume":"81","author":"DB Re","year":"2014","unstructured":"Re DB et al (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81(5):1001\u20131008","journal-title":"Neuron"},{"key":"6_CR189","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2014.09.017","volume":"1607","author":"JP Richard","year":"2015","unstructured":"Richard JP, Maragakis NJ (2015) Induced pluripotent stem cells from ALS patients for disease modeling. Brain Res 1607:15\u201325","journal-title":"Brain Res"},{"issue":"1","key":"6_CR190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0012-1606(77)90158-0","volume":"56","author":"JE Sulston","year":"1977","unstructured":"Sulston JE, Horvitz HR (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56(1):110\u2013156","journal-title":"Dev Biol"},{"issue":"7446","key":"6_CR191","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496(7446):498\u2013503","journal-title":"Nature"},{"issue":"5166","key":"6_CR192","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264(5166):1772\u20131775","journal-title":"Science"},{"issue":"6","key":"6_CR193","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"PC Wong","year":"1995","unstructured":"Wong PC et al (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14(6):1105\u20131116","journal-title":"Neuron"},{"issue":"1","key":"6_CR194","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.expneurol.2011.09.020","volume":"233","author":"LR Fischer","year":"2012","unstructured":"Fischer LR et al (2012) Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp Neurol 233(1):163\u2013171","journal-title":"Exp Neurol"},{"issue":"10","key":"6_CR195","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.freeradbiomed.2010.08.022","volume":"49","author":"TY Kostrominova","year":"2010","unstructured":"Kostrominova TY (2010) Advanced age-related denervation and fiber-type grouping in skeletal muscle of SOD1 knockout mice. Free Radic Biol Med 49(10):1582\u20131593","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"6_CR196","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.53.6.1239","volume":"53","author":"JM Shefner","year":"1999","unstructured":"Shefner JM et al (1999) Mice lacking cytosolic copper\/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 53(6):1239\u20131246","journal-title":"Neurology"},{"issue":"5778","key":"6_CR197","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boillee","year":"2006","unstructured":"Boillee S et al (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312(5778):1389\u20131392","journal-title":"Science"},{"issue":"11","key":"6_CR198","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1073\/pnas.0813339106","volume":"106","author":"CS Lobsiger","year":"2009","unstructured":"Lobsiger CS et al (2009) Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci U S A 106(11):4465\u20134470","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6_CR199","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K et al (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11(3):251\u2013253","journal-title":"Nat Neurosci"},{"issue":"1","key":"6_CR200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nbd.2012.05.014","volume":"48","author":"L Wang","year":"2012","unstructured":"Wang L et al (2012) Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Neurobiol Dis 48(1):52\u201357","journal-title":"Neurobiol Dis"},{"issue":"2","key":"6_CR201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2009.05.002","volume":"35","author":"L Wang","year":"2009","unstructured":"Wang L et al (2009) The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Neurobiol Dis 35(2):234\u2013240","journal-title":"Neurobiol Dis"},{"issue":"5","key":"6_CR202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang SH et al (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16(5):571\u2013579","journal-title":"Nat Neurosci"},{"issue":"44","key":"6_CR203","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska I et al (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 106(44):18809\u201318814","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6_CR204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/iep.12006","volume":"94","author":"MA Esmaeili","year":"2013","unstructured":"Esmaeili MA et al (2013) Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol 94(1):56\u201364","journal-title":"Int J Exp Pathol"},{"issue":"Pt 9","key":"6_CR205","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/brain\/awr159","volume":"134","author":"V Swarup","year":"2011","unstructured":"Swarup V et al (2011) Pathological hallmarks of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134(Pt 9):2610\u20132626","journal-title":"Brain"},{"key":"6_CR206","doi-asserted-by":"crossref","unstructured":"Philips T, Rothstein JD (2015) Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol 69:5.67.1\u20135.67.21","DOI":"10.1002\/0471141755.ph0567s69"},{"issue":"9","key":"6_CR207","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbadis.2013.03.012","volume":"1832","author":"P McGoldrick","year":"2013","unstructured":"McGoldrick P et al (2013) Rodent models of amyotrophic lateral sclerosis. Biochim Biophys Acta 1832(9):1421\u20131436","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"6_CR208","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.conb.2011.05.029","volume":"21","author":"S Cruz Da","year":"2011","unstructured":"Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS\/TLS in ALS and beyond. Curr Opin Neurobiol 21(6):904\u2013919","journal-title":"Curr Opin Neurobiol"},{"key":"6_CR209","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40478-014-0166-y","volume":"2","author":"RK Hukema","year":"2014","unstructured":"Hukema RK et al (2014) A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD. Acta Neuropathol Commun 2:166","journal-title":"Acta Neuropathol Commun"},{"issue":"6239","key":"6_CR210","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aaa9344","volume":"348","author":"J Chew","year":"2015","unstructured":"Chew J et\u00a0al (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348(6239):1151\u20131154","journal-title":"Science"},{"issue":"5","key":"6_CR211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861\u2013872","journal-title":"Cell"},{"issue":"5893","key":"6_CR212","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos JT et al (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321(5893):1218\u20131221","journal-title":"Science"},{"issue":"2","key":"6_CR213","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1523\/JNEUROSCI.0906-12.2013","volume":"33","author":"MW Amoroso","year":"2013","unstructured":"Amoroso MW et al (2013) Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci 33(2):574\u2013586","journal-title":"J Neurosci"},{"issue":"11","key":"6_CR214","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/nprot.2011.405","volume":"6","author":"R Krencik","year":"2011","unstructured":"Krencik R, Zhang SC (2011) Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc 6(11):1710\u20131717","journal-title":"Nat Protoc"},{"issue":"5","key":"6_CR215","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.celrep.2013.06.021","volume":"4","author":"L Roybon","year":"2013","unstructured":"Roybon L et al (2013) Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep 4(5):1035\u20131048","journal-title":"Cell Rep"},{"issue":"5","key":"6_CR216","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5966\/sctm.2013-0153","volume":"3","author":"AM Haidet-Phillips","year":"2014","unstructured":"Haidet-Phillips AM et al (2014) Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl Med 3(5):575\u2013585","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"6_CR217","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11626-011-9435-2","volume":"47","author":"S Ogawa","year":"2011","unstructured":"Ogawa S et al (2011) Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells. In Vitro Cell Dev Biol Anim 47(7):464\u2013469","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"2","key":"6_CR218","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","volume":"12","author":"S Wang","year":"2013","unstructured":"Wang S et al (2013) Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12(2):252\u2013264","journal-title":"Cell Stem Cell"},{"issue":"4","key":"6_CR219","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5966\/sctm.2011-0042","volume":"1","author":"Q Liu","year":"2012","unstructured":"Liu Q et al (2012) Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med 1(4):266\u2013278","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"6_CR220","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1582-4934.2011.01498.x","volume":"16","author":"S Salani","year":"2012","unstructured":"Salani S et al (2012) Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. J Cell Mol Med 16(7):1353\u20131364","journal-title":"J Cell Mol Med"},{"issue":"5","key":"6_CR221","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"R Darabi","year":"2012","unstructured":"Darabi R et al (2012) Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10(5):610\u2013619","journal-title":"Cell Stem Cell"}],"container-title":["Advances in Neurobiology","Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-57193-5_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T05:36:16Z","timestamp":1719293776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-57193-5_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319571911","9783319571935"],"references-count":221,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-57193-5_6","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"type":"print","value":"2190-5215"},{"type":"electronic","value":"2190-5223"}],"subject":[],"published":{"date-parts":[[2017]]}}}